表紙
市場調查報告書

穩定性同位素標識化合物的全球市場 至2024年的預測:C13 (碳13)、D (重氫)、018 (氧18)、N15標識 (氮15)

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 536512
出版日期 內容資訊 英文 146 Pages
訂單完成後即時交付
價格
穩定性同位素標識化合物的全球市場 至2024年的預測:C13 (碳13)、D (重氫)、018 (氧18)、N15標識 (氮15) Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region - Global Forecast to 2024
出版日期: 2020年01月14日內容資訊: 英文 146 Pages
簡介

全球穩定性同位素標識化合物的市場規模預測將從2019年的2億6,900萬美元,到2024年達3億1,200萬美元的規模,並以3.0%的年複合成長率 (CAGR) 成長。醫藥品、生物科技產業上研究活動的活躍,蛋白質體學研究的擴大,癌症的盛行率上升等要素促進該市場成長。可是,穩定性同位素標識化合物的高成本性,預計抑制在預測期間內該市場的成長。各類型中的重氫 (D) 標識化合物市場區隔,在預測期間內以最高年複合成長率成長。這個成長,由於主要的醫藥品產業的醫藥品研究的擴大及重氫標識化合物的容易取得而受到促進。各用途中,由於研究市場區隔,生物醫療,醫藥品,環境、生態學,及農業領域的研究活動的增加,構成了2018年的穩定性同位素標識化合物市場上最大的佔有率。

本報告提供全球穩定性同位素標識化合物的市場調查,市場及產品概要,對市場成長的各種影響因素及市場機會分析,各標識區分、用途、終端用戶、地區的趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 北美市場:各用途
  • 地區市場概要

第5章 市場概要

  • 簡介
  • 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第6章 市場分析:各類型

  • 簡介
  • 重氫
  • 碳13
  • 氧18
  • 氮15
  • 其他

第7章 市場分析:各用途

第7章 市場分析:各用途

  • 簡介
  • 研究用途
    • 生物醫療研究
    • 醫藥品研究
    • 環境、生態學研究
    • 農業研究
  • 臨床診斷
  • 產業用途
  • 其他

第8章 市場分析:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 學術、研究機關
  • 醫院、診斷中心
  • 其他

第9章 地區分析

  • 簡介
  • 北美 美國 加拿大
  • 歐洲 德國 英國 法國 義大利 西班牙 其他
  • 亞太地區 中國 日本 印度 澳洲 其他
  • 其他地區

第10章 競爭環境

  • 簡介
  • 市場佔有率分析
  • 競爭模式
  • 競爭領導製圖

第11章 企業簡介

  • CAMBRIDGE ISOTOPE LABORATORIES, INC.
  • MERCK KGAA
  • URENCO LIMITED
  • ISOSCIENCES, LLC (AN MDP CHEMICALS COMPANY)
  • MEDICAL ISOTOPES, INC.
  • OMICRON BIOCHEMICALS, INC.
  • NORDION (CANADA) INC. (A STERIGENICS INTERNATIONAL LLC COMPANY)
  • TRACE SCIENCES INTERNATIONAL
  • ALSACHIM
  • 大陽日酸
  • PERKINELMER INC.
  • ROTEM INDUSTRIES ISRAEL LTD、其他

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PH 5445

"The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019-2024)."

The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period.

"By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period."

Based on component, the stable isotope-labeled compounds market is segmented into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2 labeled compounds segment accounted for the largest market share in 2018. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by growing drug research in the pharmaceutical industry and the increasing availability of deuterium-labeled compounds.

"By application, the research segment dominated the stable isotope labeled compounds market in 2018."

Based on technology, the stable isotope-labeled compounds market is segmented into research, clinical diagnostics, industrial applications, and other applications. The research segment accounted for the largest share of the stable isotope-labeled compounds market in 2018, owing to rising research activities in the biomedical, pharmaceutical, environmental & ecological, and agricultural sectors.

"North America stable isotope labeled compounds market is expected to witness the highest growth during the forecast period."

The North America region market is estimated to grow at the highest CAGR during the forecast period, primarily due to the growing pharmaceutical and biopharmaceutical industry, support from the Isotope Production and Distribution Program Fund, and the presence of a large nuclear industry are driving market growth in the region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-21%, Tier 2-26%, and Tier 3-53%
  • By Designation: C-level-32%, Director-level-26%, and Others-42%
  • By Region: North America-34%, Europe-29%, Asia Pacific-27%, RoW-10%

The prominent players operating in the global stable isotope labeled compounds market include: PerkinElmer Inc. (US), Merck KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US), Omicron Biochemicals, Inc. (US), Trace Sciences International (US), Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem Industries Israel Ltd. (Israel).

Research Coverage:

The report analyzes the stable isotope labeled compounds market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the stable isotope labeled compounds market
  • Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the stable isotope labeled compounds market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global stable isotope labeled compounds market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the leading players in the stable isotope labeled compounds market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKET SCOPE
    • 1.2.2 MARKETS COVERED
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 KEY DATA FROM SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.5 DATA TRIANGULATION
    • 2.5.1 ASSUMPTIONS FOR THE STUDY
    • 2.5.2 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 STABLE ISOTOPE-LABELED COMPOUNDS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION (2018)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increase in research activities in the pharmaceutical & biotechnology sectors
      • 5.2.1.2 Growing proteomics research
      • 5.2.1.3 Growing prevalence of cancer
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of stable isotope-labeled compounds
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing investments in pharmaceutical R&D in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals

6 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 HYDROGEN-2
    • 6.2.1 GROWING APPLICATIONS OF H-2 IN PHARMACEUTICAL RESEARCH WILL DRIVE THE DEMAND FOR LABELED COMPOUNDS
  • 6.3 CARBON-13
    • 6.3.1 GROWING NUMBER OF METABOLOMICS STUDIES AND APPLICATIONS IN DISEASE DIAGNOSIS ARE DRIVING MARKET GROWTH
  • 6.4 OXYGEN-18
    • 6.4.1 INCREASING RESEARCH ON CANCER IS EXPECTED TO DRIVE THE DEMAND FOR OXYGEN-18-LABELED ISOTOPES
  • 6.5 NITROGEN-15
    • 6.5.1 EXPANDING APPLICATIONS OF N-15 IN AGRICULTURAL INVESTIGATION AND RISING RESEARCH ARE LIKELY TO DRIVE MARKET DEMAND
  • 6.6 OTHER STABLE ISOTOPES

7 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 RESEARCH APPLICATIONS
    • 7.2.1 BIOMEDICAL RESEARCH
      • 7.2.1.1 Increasing number of biomedical research activities involving stable isotopes to drive the stable isotope-labeled compounds market for biomedical research
    • 7.2.2 PHARMACEUTICAL RESEARCH
      • 7.2.2.1 Stable isotopically modified pharmaceutical agents offer reduced side-effects, improved oral bioavailability, and increased half-life-key factors driving market growth
    • 7.2.3 ENVIRONMENTAL & ECOLOGICAL RESEARCH
      • 7.2.3.1 Increasing use of stable to study the feeding ecology of living or extinct animal species through the analysis of their ratios in carcasses or remains to drive market growth
    • 7.2.4 AGRICULTURAL RESEARCH
      • 7.2.4.1 Increasing use of stable isotopes to prevent soil pollution and contamination and facilitate maximum crop production to drive growth in this market
  • 7.3 CLINICAL DIAGNOSTICS
    • 7.3.1 INCREASING ADOPTION OF PET SCANS AND GAMMA IMAGING FOR DISEASE STAGING TO SUPPORT MARKET GROWTH
  • 7.4 INDUSTRIAL APPLICATIONS
    • 7.4.1 GROWING APPLICATION OF STABLE ISOTOPES IN THE NUCLEAR INDUSTRY AND THE INCREASING NUMBER OF NUCLEAR REACTORS TO SUPPORT MARKET GROWTH
  • 7.5 OTHER APPLICATIONS

8 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 INCREASE IN R&D ACTIVITIES TO DRIVE THE DEMAND FOR STABLE ISOTOPE-LABELED COMPOUNDS AMONG PHARMA & BIOTECH COMPANIES
  • 8.3 ACADEMIC & RESEARCH INSTITUTES
    • 8.3.1 GROWING RESEARCH ON VARIOUS TREATMENT THERAPIES IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
  • 8.4 HOSPITALS & DIAGNOSTIC CENTERS
    • 8.4.1 ADOPTION OF STABLE ISOTOPES HAS INCREASED OWING TO THE RISING PREVALENCE OF TARGET DISEASES
  • 8.5 OTHER END USERS

9 STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American stable isotope-labeled compounds market
    • 9.2.2 CANADA
      • 9.2.2.1 Availability of funding will drive the market in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the fastest-growing market in Europe
    • 9.3.2 UK
      • 9.3.2.1 Favorable scenario for environmental research and increasing prevalence of cancer are key growth drivers in the UK
    • 9.3.3 FRANCE
      • 9.3.3.1 France has a large and well-developed biotech industry
    • 9.3.4 ITALY
      • 9.3.4.1 Strong government support for research has stimulated market growth in Italy
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing research activities and expenditure shows significant market growth potential in Spain
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 China dominates the stable isotope-labeled compounds market in the APAC
    • 9.4.2 JAPAN
      • 9.4.2.1 Growing support and funding have raised research intensity in Japan
    • 9.4.3 INDIA
      • 9.4.3.1 Government initiatives have strengthened the life science industry in India
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Growing funding for research and collaborations have supported market growth in Australia
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SCENARIO
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 10.4.1 VISIONARY LEADERS
    • 10.4.2 INNOVATORS
    • 10.4.3 DYNAMIC DIFFERENTIATORS
    • 10.4.4 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View)*

  • 11.1 CAMBRIDGE ISOTOPE LABORATORIES
  • 11.2 MERCK KGAA
  • 11.3 URENCO LIMITED
  • 11.4 ISOSCIENCES
  • 11.5 MEDICAL ISOTOPES
  • 11.6 OMICRON BIOCHEMICALS
  • 11.7 TRACE SCIENCES INTERNATIONAL
  • 11.8 ALSACHIM
  • 11.9 TAIYO NIPPON SANSO CORPORATION
  • 11.10 PERKINELMER
  • 11.11 ROTEM INDUSTRIES ISRAEL
  • 11.12 BOC SCIENCES
  • 11.13 CORTECNET
  • 11.14 ISOFLEX
  • 11.15 HUAYI ISOTOPES CO.
  • 11.16 MESBAH ENERGY CO.
  • 11.17 SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
  • 11.18 13C MOLECULAR
  • 11.19 C/D/N ISOTOPES
  • 11.20 SHOKO CO.

Business Overview, Products Offered, Recent Developments, Competitive Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: COMPANY DRUG PIPELINES, 2019
  • TABLE 2: TOP INVESTORS IN R&D, 2016 VS. 2017
  • TABLE 3: GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 4: GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS
  • TABLE 5: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 7: NORTH AMERICA: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: EUROPE: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: APAC: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 10: CARBON-13-LABELED COMPOUNDS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: APAC: C CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 14: OXYGEN-18-LABELED COMPOUNDS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: EUROPE: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: APAC: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 18: NITROGEN-15-LABELED COMPOUNDS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: EUROPE: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: APAC: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 22: OTHER STABLE ISOTOPES MARKET, BY REGION, 2017-2022 (USD THOUSAND)
  • TABLE 23: NORTH AMERICA: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 24: EUROPE: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 25: APAC: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 26: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 27: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 35: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 38: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 39: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 41: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 42: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 43: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 44: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 48: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 50: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 52: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 53: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 54: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 55: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 56: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 58: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 59: APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD THOUSAND)
  • TABLE 60: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 61: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 69: CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 70: CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 71: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 72: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 77: GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 78: UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 80: UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 81: FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 82: FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 83: FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 84: ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 85: ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 86: ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 87: SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 88: SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 89: SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 90: PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES (2016)
  • TABLE 91: ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 92: ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 93: ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 94: NUMBER OF NUCLEAR REACTORS IN THE ASIA PACIFIC (AUGUST 2019)
  • TABLE 95: ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 96: ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 98: ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 99: CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 101: CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 102: JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 103: JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 104: JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 105: INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 106: INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 107: INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 108: AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 109: AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 110: AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 111: ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 112: ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 113: ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 114: ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017-2024 (USD THOUSAND)
  • TABLE 115: ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017-2024 (USD THOUSAND)
  • TABLE 116: ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017-2024 (USD THOUSAND)
  • TABLE 117: AGREEMENTS (2016-2019)
  • TABLE 118: PRODUCT LAUNCHES (2016-2019)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4: MARKET SIZE ESTIMATION: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
  • FIGURE 5: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
  • FIGURE 10: INCREASE IN RESEARCH IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS WILL DRIVE MARKET GROWTH
  • FIGURE 11: RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2018
  • FIGURE 12: NORTH AMERICA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14: NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
  • FIGURE 15: ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
  • FIGURE 16: MARKET RANKING OF KEY PLAYERS, 2018
  • FIGURE 17: COMPETITIVE LEADERSHIP MAPPING: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
  • FIGURE 18: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 19: URENCO LIMITED: COMPANY SNAPSHOT (2018)
  • FIGURE 20: TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 21: PERKINELMER: COMPANY SNAPSHOT (2018)